21創(chuàng)新論壇:Not to be naive——the making of long-lived humoral imm... (23-02-21) |
21創(chuàng)新論壇:The Tumour-associated macrophages——Nurture vs nature (23-02-17) |
21創(chuàng)新論壇:脂滴發(fā)生和脂肪組織分化的分子機(jī)制 (22-12-26) |
21創(chuàng)新論壇:結(jié)核分枝桿菌的宿主免疫逃逸新機(jī)制 (22-11-18) |
21創(chuàng)新論壇:腫瘤中B細(xì)胞亞群異質(zhì)性和功能多樣性 (22-11-18) |
21創(chuàng)新論壇:重構(gòu)哺乳動(dòng)物血管發(fā)育早期的動(dòng)靜脈特化模式 (22-11-14) |
21創(chuàng)新論壇:表觀(guān)遺傳——基礎(chǔ)研究與新藥研發(fā)實(shí)踐 (22-11-07) |
21創(chuàng)新論壇:Mitochondrial production of metabolic precursors is ess... (22-10-22) |
21創(chuàng)新論壇:細(xì)菌脂代謝——粘菌素耐藥與毒力 (22-10-22) |
21創(chuàng)新論壇: Sensing and Sensibility - The regulation and function ... (22-09-25) |
?上海全球視野論壇第12期:Global Health and Malaria Control (22-07-13) |
21創(chuàng)新論壇:探索線(xiàn)粒體NADPH的功能 (22-06-21) |
21創(chuàng)新論壇:Structural insights into TCR-CD3 inhibition by choleste... (22-06-09) |
21創(chuàng)新論壇:Targeting Protein-Protein Interactions in Cancer (22-06-09) |
21創(chuàng)新論壇:Targeting tumor microenvironment to rejuvenate T cell i... (22-05-26) |
21創(chuàng)新論壇:代謝流的動(dòng)態(tài)追蹤與系統(tǒng)定量 (22-05-19) |
21創(chuàng)新論壇:Sugar defeats the Hippo during tumor initiation (22-05-10) |
21創(chuàng)新論壇:免疫性血小板減少癥發(fā)病機(jī)制研究進(jìn)展 (22-05-03) |
上海全球視野論壇第11期:Leveraging Pandemic Surveillance to Address... (22-04-21) |
21創(chuàng)新論壇:Immunological Mechanisms of Epithelial Cancer Defense (22-04-19) |